Yale University Nephrology Clinical Trials Program

New Haven, Connecticut 06510

1 studies enrolling now · 1 studies all time

What they study most

IgA Nephropathy

Studies at this site

• Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy — Recruiting now